Togo COVID-19 Emergency Response and Systems Preparedness Strengthening Project

Abstract*

The proposed project will support the implementation of Togo COVID-19 Plan. It will support Strengthening Multi-sector, National Institutions and Platforms for Policy Development and Coordination of Prevention and Preparedness; Support National and Sub-national, Prevention and Preparedness; and Implementation and Monitoring and Evaluation. The proposed project will consist of three components: Component 1: Emergency COVID-19 Response - Case Detection... Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Togo.

Key Details

Project Details

Project ID
P173880
Status
Closed
Team Leader
Voahirana Rajoela , Fatoumata Barry
Borrower 2
Republic of Togo

Country
Togo
Disclosure Date
April 9, 2020
Approval Date
(as of board presentation)
April 17, 2020
Effective Date
April 28, 2020

Total Project Cost 1
US$ 62.60 million
Implementing Agency
Ministère de la Santé, de l’hygiène Publique et de l’accès universel aux soins
Region
Western and Central Africa
Fiscal Year 3
2020

Commitment Amount
US$ 62.60 million
Environmental Category
N/A
Environmental and Social Risk
Substantial
Closing Date
June 30, 2024

Consultant Services required
No
Last Stage Reached
BANK APPROVED
Last Update Date
April 22, 2024

Associated Projects
P177956
P176335

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Health Systems and Policies100%
- FY17 - Health Finance100%
- FY17 - Health Service Delivery100%
- FY17 - Health System Strengthening100%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Grant	29.05
Health Emergency Preparedness and Response Multi-Donor Trust	4.50
IDA Credit	29.05

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	58.10
IBRD + IDA Commitment	58.10

Lending Instrument
Grant Amount	4.50
Total Project Cost**	62.60

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Jun 7, 2022	IDA-69420	Loan Disb	3,138,491.00
Jul 12, 2022	IDA-69420	Loan Disb	519,363.30
Apr 20, 2022	IDA-D8640	Loan Disb	300,159.75
Jun 15, 2022	IDA-69420	Int Charges	5,737.67
Jun 15, 2022	IDA-69420	Int Charges	5,737.67
Jun 15, 2022	IDA-66280	Int Charges	14,502.50
Jun 15, 2022	IDA-66280	Int Charges	14,502.50
Nov 29, 2021	IDA-D8640	Loan Disb	1,102,248.00
Nov 23, 2021	IDA-D8640	Loan Disb	3,460,565.50
Jun 16, 2021	IDA-66280	Int Charges	11,922.06
Jun 16, 2021	IDA-66280	Int Charges	11,922.06
Nov 19, 2021	IDA-D8640	Loan Disb	1,500,050.00
Oct 7, 2021	IDA-D8640	Loan Disb	177,223.28
Sep 13, 2021	IDA-66280	Loan Disb	87,780.03
Jun 15, 2021	IDA-66280	Int Charges	538.79
Jun 15, 2021	IDA-66280	Int Charges	538.79
Apr 29, 2021	IDA-66280	Loan Disb	665,328.94
Nov 24, 2020	IDA-D6260	Loan Disb	634,834.30
Jan 4, 2021	IDA-66280	Loan Disb	3,769,142.00
Dec 28, 2020	IDA-D6260	Loan Disb	1,870,114.60
Oct 19, 2020	IDA-66280	Loan Disb	-448,485.00
Dec 16, 2020	IDA-D6260	Loan Disb	381,465.16
Dec 15, 2020	IDA-66280	Int Charges	125.51
Dec 15, 2020	IDA-66280	Int Charges	125.51
Dec 15, 2020	IDA-66280	Int Charges	1,197.18
Dec 15, 2020	IDA-66280	Int Charges	1,197.18
Jun 16, 2023	IDA-69420	Int Charges	457.65
Dec 15, 2023	IDA-66280	Int Charges	14,996.93
Dec 15, 2023	IDA-66280	Int Charges	14,996.93
Dec 15, 2023	IDA-69420	Int Charges	36,557.90
Dec 15, 2023	IDA-69420	Int Charges	36,557.90
Jun 16, 2023	IDA-69420	Int Charges	33,383.86
Jun 16, 2023	IDA-69420	Int Charges	33,383.86
Jun 15, 2023	IDA-66280	Int Charges	-46.44
Jun 15, 2023	IDA-66280	Int Charges	55.90
Jun 15, 2023	IDA-66280	Int Charges	55.90
Jun 16, 2023	IDA-66280	Int Charges	14,907.68
Jun 16, 2023	IDA-66280	Int Charges	14,907.68
Jun 15, 2023	IDA-66280	Int Charges	46.44
Feb 24, 2023	IDA-D8640	Loan Disb	17,857.81
Jan 19, 2023	IDA-D8640	Loan Disb	39,324.21
Mar 15, 2023	IDA-69420	Loan Disb	1,601,080.20
Mar 15, 2023	IDA-D8640	Loan Disb	31,779.93
Oct 31, 2022	IDA-69420	Loan Disb	419,005.62
Oct 18, 2022	IDA-66280	Loan Cancel	53,131.57
Oct 18, 2022	IDA-66280	Loan Disb	-42,648.01
Oct 24, 2022	IDA-D8640	Loan Disb	51,744.45
Dec 7, 2022	IDA-D8640	Loan Disb	29,052.64
Dec 14, 2022	IDA-D8640	Loan Disb	18,961.14
Oct 18, 2022	IDA-D6260	Loan Cancel	15,773.30
Sep 21, 2022	IDA-69420	Loan Disb	228,834.08
Dec 15, 2022	IDA-66280	Int Charges	14,644.17
Dec 15, 2022	IDA-66280	Int Charges	14,644.17
Oct 18, 2022	IDA-D6260	Loan Disb	-14,654.14
Dec 15, 2021	IDA-66280	Int Charges	592.75
Dec 15, 2021	IDA-66280	Int Charges	592.75
Dec 1, 2022	IDA-69420	Loan Disb	81,080.01
Dec 28, 2022	IDA-69420	Loan Disb	7,360.44
Dec 15, 2022	IDA-69420	Int Charges	626.95
Dec 15, 2022	IDA-69420	Int Charges	626.95
Dec 15, 2022	IDA-69420	Int Charges	26,589.28
Dec 15, 2022	IDA-69420	Int Charges	26,589.28
Dec 15, 2021	IDA-66280	Int Charges	15,437.98
Apr 17, 2020	IDA-66280	Loan Commitment	4,050,000.00
Apr 17, 2020	IDA-D6260	Loan Commitment	4,050,000.00
Dec 21, 2021	IDA-70260	Loan Commitment	12,500,000.00
Dec 21, 2021	IDA-D9610	Loan Commitment	12,500,000.00
Jun 10, 2021	IDA-69420	Loan Commitment	12,500,000.00
Jun 10, 2021	IDA-D8640	Loan Commitment	12,500,000.00
Jun 18, 2024	IDA-66280	Int Charges	14,653.76
Jun 27, 2024	IDA-70260	Loan Disb	93,013.42
Jun 18, 2024	IDA-69420	Int Charges	35,721.36
Jun 18, 2024	IDA-69420	Int Charges	35,721.36
Jun 28, 2024	IDA-D9610	Loan Disb	10,521.71
Jun 17, 2024	IDA-D9610	Loan Disb	124,366.40
Jun 27, 2024	IDA-70260	Loan Disb	498,706.22
Jun 28, 2024	IDA-70260	Loan Disb	3,405,469.50
Apr 23, 2024	IDA-70260	Int Charges	7,574.69
Apr 23, 2024	IDA-70260	Int Charges	7,574.69
Aug 19, 2024	IDA-70260	Loan Disb	636,956.30
Jul 11, 2024	IDA-70260	Loan Disb	240,698.23
Jun 18, 2024	IDA-66280	Int Charges	14,653.76
Feb 27, 2024	IDA-D9610	Loan Disb	2,918,149.00
Aug 27, 2024	IDA-70260	Loan Disb	1,116,253.40
Jan 30, 2024	IDA-D9610	Loan Disb	232,145.52
Jul 9, 2024	IDA-70260	Loan Disb	458,027.12
Jul 23, 2024	IDA-70260	Loan Disb	298,062.22
Dec 28, 2023	IDA-D9610	Loan Disb	8,112,480.00
Jan 3, 2024	IDA-70260	Loan Disb	3,704,603.80
Jun 16, 2023	IDA-69420	Int Charges	457.65
Dec 9, 2020	IDA-D6260	Loan Disb	151,900.02
Jun 2, 2020	IDA-D6260	Loan Disb	420,189.25
Jun 2, 2020	IDA-66280	Loan Disb	425,675.78
Jun 17, 2020	IDA-D6260	Loan Disb	65,100.00
Oct 19, 2020	IDA-D6260	Loan Disb	448,485.00
Jul 17, 2020	IDA-D6260	Loan Disb	290,834.28
Dec 15, 2021	IDA-66280	Int Charges	15,437.98
Sep 27, 2022	IDA-D8640	Loan Disb	48,333.54
Mar 21, 2022	IDA-69420	Loan Disb	168,630.92
Mar 21, 2022	IDA-69420	Loan Disb	3,349,095.00
Dec 22, 2021	IDA-D8640	Loan Disb	878,630.25
Feb 8, 2022	IDA-D8640	Loan Disb	875,212.25
Aug 3, 2022	IDA-D8640	Loan Disb	24,363.90
Apr 8, 2022	IDA-D6260	Loan Disb	7,895.32
Dec 7, 2021	IDA-D8640	Loan Disb	344,898.94
Mar 14, 2022	IDA-D8640	Loan Disb	2,158,506.20

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Progress towards achievement of PDO	Satisfactory	2024-11-07
Monitoring and Evaluation	Satisfactory	2024-11-07
Overall Implementation Progress (IP)	Satisfactory	2024-11-07
Project Management	Satisfactory	2024-11-07
Procurement	Satisfactory	2024-11-07
Financial Management	Satisfactory	2024-11-07

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Activation of public health Emergency Operations Centre or a coordination mechanism for COVID-19 Value NO YES YES
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Designated acute healthcare facilities with isolation capacity Value 1.00 38.00 9.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents Value 1.00 12.00 3.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Suspected cases of COVID-19 reported and investigated based on national guidelines Value 483.00 28608.00 1500.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Population fully vaccinated, which is included in the priority population targets defined in the national plan Value 8.00 27.50 30.00
Date October 31, 2021 November 15, 2022 June 30, 2024
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Points of entry staff trained on screening and management of suspected COVID-19 case Value 1.00 180.00 500.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Regional and district’s Laboratories equipped Value 0.00 12.00 40.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Training attended by project management unit members and technical consultants Value 0.00 3.00 5.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Suspected COVID-19 cases diagnosed by designated laboratories within 24 hrs Value 5.00 5.00 50.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Medical and veterinary laboratory personnel trained Value 62.00 170.00 1000.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Complaints received and addressed within the Grievance Redress Mechanism (GRM) specified timeframe Value 0.00 96.00 80.00
Date October 31, 2020 November 15, 2023 June 30, 2024
Comment
Designated laboratories with PPE, regent and infection control products and supplies, without stock-outs in last two weeks Value 0.00 12.00 3.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Designated laboratories with staff trained to conduct COVID-19 diagnosis Value 1.00 13.00 9.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
M&E system established to monitor COVID-19 preparedness and response plan. Value NO YES YES
Date April 28, 2020 July 14, 2022 March 31, 2022
Comment
Health staff trained in infection prevention per Ministry of Health (MoH) approved protocols Value 50.00 1101.00 1000.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Proportion of vaccination sites that transmit their data via DHIS2 Value 65.00 97.00 85.00
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment
Diagnosed cases treated in the designated treatment centers per approved protocol Value 0.00 15.00 80.00
Date April 28, 2020 March 31, 2022 March 31, 2022
Comment
Vaccinators trained on GBV/SEA/SH Value 568.00 5188.00 4600.00
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment

Estimated target populations who will be prioritized for access to vaccines, stratified by target group and geographic location	Value	425501.00	1568640.00	1651200.00
	Date	October 31, 2021	November 15, 2023	December 31, 2023
	Comment

Key gender-responsive messages and materials developed for public communications and advocacy, in alignment with demand plan Value No Yes Yes
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment
Beneficiaries reporting that community engagement and outreach meet their needs Value 0.00 0.00 50.00
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment
Vaccination sites with functional cold chain Value 75.00 100.00 95.00
Date March 31, 2021 November 15, 2023 December 31, 2023
Comment
Community Engagement and monitoring of interventions against GBV and SEA/SH reported Value No Yes Yes
Date October 31, 2021 November 15, 2023 June 30, 2024
Comment
Designated laboratories with essential diagnostic equipment for diseases with epidemic potential Value 12.00 12.00 40.00
Date May 30, 2023 November 15, 2023 June 30, 2024
Comment
Women who responded correctly to 70 percent of questions on COVID-19 vaccines Value 28.00 28.00 60.00
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment
Recorders trained in the use of the data digitization platform for the COVID-19 vaccination campaign Value 0.00 2016.00 2500.00
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment
People vaccinated in hesitancy/refusal areas reached by communication activities Value 0.00 27.00 50.00
Date November 30, 2021 November 15, 2023 December 31, 2023
Comment
Eligibility for vaccination criteria include informal and/or volunteer health workers Value No Yes Yes
Date October 31, 2021 November 15, 2023 December 31, 2023
Comment

Designated acute healthcare facilities with isolation capacity	Value	1.00	38.00	9.00
	Date	April 28, 2020	March 31, 2022	March 31, 2022
	Comment

Suspected cases of COVID-19 reported and investigated based on national guidelines	Value	483.00	28608.00	1500.00
	Date	April 28, 2020	March 31, 2022	March 31, 2022
	Comment

Population fully vaccinated, which is included in the priority population targets defined in the national plan	Value	8.00	27.50	30.00
	Date	October 31, 2021	November 15, 2022	June 30, 2024
	Comment

Regional and district’s Laboratories equipped	Value	0.00	12.00	40.00
	Date	April 28, 2020	March 31, 2022	March 31, 2022
	Comment

Suspected COVID-19 cases diagnosed by designated laboratories within 24 hrs	Value	5.00	5.00	50.00
	Date	April 28, 2020	March 31, 2022	March 31, 2022
	Comment

Medical and veterinary laboratory personnel trained	Value	62.00	170.00	1000.00
	Date	April 28, 2020	March 31, 2022	March 31, 2022
	Comment

Proportion of vaccination sites that transmit their data via DHIS2	Value	65.00	97.00	85.00
	Date	October 31, 2021	November 15, 2023	December 31, 2023
	Comment

Vaccinators trained on GBV/SEA/SH	Value	568.00	5188.00	4600.00
	Date	October 31, 2021	November 15, 2023	December 31, 2023
	Comment

Vaccination sites with functional cold chain	Value	75.00	100.00	95.00
	Date	March 31, 2021	November 15, 2023	December 31, 2023
	Comment

Women who responded correctly to 70 percent of questions on COVID-19 vaccines	Value	28.00	28.00	60.00
	Date	October 31, 2021	November 15, 2023	December 31, 2023
	Comment

Togo COVID-19 Emergency Response and Systems Preparedness Strengthening Project

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS